June 23, 2018 – Dr. Elinore McCance-Katz, the Trump administration’s director of the Substance Abuse and Mental Health Services Administration, helped pioneer opioid addiction treatment with buprenorphine in clinical trials in the 1990s. She also helped create the training for doctors who want to prescribe it. What follows is a condensed interview with her.
How much of your time is spent addressing the opioid epidemic?
I probably spend half of my time on it. I also, of course, spend time on serious mental illness issues, and on planning; keeping the organization running; making sure all the various components of what is a large and complicated organization are continuing and getting worked on.
ALWAYS WITH YOU – Nov. 2, 2024 - Archaeologists have uncovered a previously unknown effect…
TURN OFF CNN – Nov. 7, 2024 - At Toshikazu Kawaguchi’s book signings, it’s not…
86ed AGAIN? – NOV. 4, 2024 - Two previous rounds of employee cuts in September…
BY A NOSE – Nov. 5, 2024 - Thoroughbred owner and recovering alcoholic Gino Roncelli…
VIDEO – NO VALUE AT ALL – Nov. 4, 2024 - It all started innocently…
WHAT WOULD? – Nov. 4, 2024 - Stephan Lindner, Ph.D., is lead author on a…